Frank Rich details the influence of lobbyists despite President Obama's campaign promise to cut that influence in the New York Times.
Obama’s promise to make Americans trust the government again was not just another campaign bullet point; it’s the foundation of his brand of governance and essential to his success in office. At the first anniversary of the TARP bailout of the banks, we can see how far he has to go. Americans’ continued suspicion that Washington is in cahoots with powerful interests in joints like Tosca is contributing to their confusion and skepticism about what’s happening out of view in the battle over health care reform.
The public is not wrong. The administration’s legislative deals with the pharmaceutical companies were made in back rooms. Business Week reported in early August that the UnitedHealth Group and its fellow insurance giants had already quietly rounded up moderate Democrats in the House to block any public health care option that would compete with them for business. UnitedHealth’s hired Beltway gunslingers include both Elmendorf Strategies and Daschle, a public supporter of the public option who nonetheless does some of his “wink, wink” counseling for UnitedHealth. The company’s in-house lobbyist is a former chief of staff to Steny Hoyer, the House majority leader. Gephardt consults there too.
Rich points out that Obama can still make good on his campaign pledge. However, the clear influence to date of those with insider connections on reform of both health care and Wall Street remains one of the more disappointing aspects of the new administration.
--Ballard Burgher
Monday, October 5, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment